Skip to main content
. 2014 Nov 27;7:2175–2181. doi: 10.2147/OTT.S70654

Table 2.

Tumor response (n=78)

Response Patients, n (%)
Overall response rate 42 (53.8)
Complete response 9 (11.5)
Partial response 33 (42.3)
Stable disease 22 (28.2)
Progressive disease 13 (16.7)
Unevaluable 1 (1.3)